Tissue Factor Expressed by Neutrophils: Another Piece in the Vascular Inflammation Puzzle

Seminars in Thrombosis and Hemostasis

Volumn 41, Issue 7, 2015, Pages 728-736

  Maugeri, Norma ^a   Manfredi, Angelo A ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

autoimmune diseases; immunothrombosis; neutrophils; thromboinflammation; tissue factor

Indexed keywords

THROMBOPLASTIN;

AUTOIMMUNE DISEASE; CONFERENCE PAPER; HUMAN; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; VASCULITIS; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; PATHOLOGY; THROMBOSIS;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; NEUTROPHILS; THROMBOPLASTIN; THROMBOSIS;

EID: 84943637897     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0035-1564043     Document Type: Conference Paper

References (103)

1. Zhao P., Metcalf M., Bunnett N. W. Biased signaling of protease-activated receptors. Front Endocrinol (Lausanne): 2014; 5 67
2. Pawlinski R., Mackman N. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med: 2004; 32 (5, Suppl): S293 S297
3. Mitroulis I., Kambas K., Anyfanti P., Doumas M., Ritis K. The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention. Expert Opin Ther Targets: 2011; 15 1 75 89
4. Maugeri N., Rovere-Querini P., Evangelista V., et al. An intense and short-lasting burst of neutrophil activation differentiates early acute myocardial infarction from systemic inflammatory syndromes. PLoS ONE: 2012; 7 6 e39484
5. Borregaard N., Sorensen O. E., Theilgaard-Mönch K. Neutrophil granules: a library of innate immunity proteins. Trends Immunol: 2007; 28 8 340 345
6. Pham C. T. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol: 2006; 6 7 541 550
7. Mócsai A. Diverse novel functions of neutrophils in immunity, inflammation, and beyond. J Exp Med: 2013; 210 7 1283 1299
8. Mantovani A., Cassatella M. A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol: 2011; 11 8 519 531
9. Maugeri N., Campana L., Gavina M., et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost: 2014; 12 12 2074 2088
10. Leshner M., Wang S., Lewis C., et al. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front Immunol: 2012; 3 307
11. Manfredi A. A., Covino C., Rovere-Querini P., Maugeri N. Instructive influences of phagocytic clearance of dying cells on neutrophil extracellular trap generation. Clin Exp Immunol: 2015; 179 1 24 29
12. Clark S. R., Ma A. C., Tavener S. A., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med: 2007; 13 4 463 469
13. Yipp B. G., Kubes P. NETosis: how vital is it? Blood: 2013; 122 16 2784 2794
14. Papayannopoulos V., Metzler K. D., Hakkim A., Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol: 2010; 191 3 677 691
15. Radic M., Marion T. N. Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity. Semin Immunopathol: 2013; 35 4 465 480
16. Kaplan M. J., Radic M. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol: 2012; 189 6 2689 2695
17. Dale D. C., Boxer L., Liles W. C. The phagocytes: neutrophils and monocytes. Blood: 2008; 112 4 935 945
18. Zemans R. L., Colgan S. P., Downey G. P. Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol: 2009; 40 5 519 535
19. Zarbock A., Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol: 2008; 172 1 1 7
20. Sreeramkumar V., Leiva M., Stadtmann A., et al. Coordinated and unique functions of the E-selectin ligand ESL-1 during inflammatory and hematopoietic recruitment in mice. Blood: 2013; 122 24 3993 4001
21. Totani L., Evangelista V. Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol: 2010; 30 12 2357 2361
22. Manfredi A. A., Rovere-Querini P., Maugeri N. Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr Opin Hematol: 2010; 17 1 3 8
23. Maugeri N., Rovere-Querini P., Baldini M., Sabbadini M. G., Manfredi A. A. Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis. Clin Exp Immunol: 2009; 156 3 395 404
24. Ramirez G. A., Maugeri N., Sabbadini M. G., Rovere-Querini P., Manfredi A. A. Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. Clin Exp Immunol: 2014; 175 2 150 166
25. Cera M. R., Fabbri M., Molendini C., et al. JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. J Cell Sci: 2009; 122 Pt 2 268 277
26. Sreeramkumar V., Adrover J. M., Ballesteros I., et al. Neutrophils scan for activated platelets to initiate inflammation. Science: 2014; 346 6214 1234 1238
27. Maugeri N., Baldini M., Ramirez G. A., Rovere-Querini P., Manfredi A. A. Platelet-leukocyte deregulated interactions foster sterile inflammation and tissue damage in immune-mediated vessel diseases. Thromb Res: 2012; 129 3 267 273
28. Nacher M., Hidalgo A. Fire within the vessels: interactions between blood cells and inflammatory vascular injury. Front Biosci (Schol Ed): 2011; 3 1089 1100
29. Hidalgo A., Chang J., Jang J. E., Peired A. J., Chiang E. Y., Frenette P. S. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med: 2009; 15 4 384 391
30. Kambas K., Mitroulis I., Ritis K. The emerging role of neutrophils in thrombosis-the journey of TF through NETs. Front Immunol: 2012; 3 385
31. von Brühl M. L., Stark K., Steinhart A., et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med: 2012; 209 4 819 835
32. Todoroki H., Nakamura S., Higure A., et al. Neutrophils express tissue factor in a monkey model of sepsis. Surgery: 2000; 127 2 209 216
33. Higure A., Okamoto K., Hirata K., et al. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis. Thromb Haemost: 1996; 75 5 791 795
34. Maugeri N., Brambilla M., Camera M., et al. Human polymorphonuclear leukocytes produce and express functional tissue factor upon stimulation. J Thromb Haemost: 2006; 4 6 1323 1330
35. Ritis K., Doumas M., Mastellos D., et al. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol: 2006; 177 7 4794 4802
36. Baldini M., Manfredi A. A., Maugeri N. Targeting platelet-neutrophil interactions in giant-cell arteritis. Curr Pharm Des: 2014; 20 4 567 574
37. Andonegui G., Kerfoot S. M., McNagny K., Ebbert K. V., Patel K. D., Kubes P. Platelets express functional Toll-like receptor-4. Blood: 2005; 106 7 2417 2423
38. Rafail S., Ritis K., Schaefer K., et al. Leptin induces the expression of functional tissue factor in human neutrophils and peripheral blood mononuclear cells through JAK2-dependent mechanisms and TNFalpha involvement. Thromb Res: 2008; 122 3 366 375
39. Maugeri N., Giordano G., Petrilli M. P., et al. Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug? J Thromb Haemost: 2006; 4 12 2593 2598
40. Maugeri N., Malato S., Femia E. A., et al. Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia. Blood: 2011; 118 12 3359 3366
41. Darbousset R., Thomas G. M., Mezouar S., et al. Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood: 2012; 120 10 2133 2143
42. Palabrica T., Lobb R., Furie B. C., et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature: 1992; 359 6398 848 851
43. Furie B., Furie B. C. Mechanisms of thrombus formation. N Engl J Med: 2008; 359 9 938 949
44. Maugeri N., Baldini M., Rovere-Querini P., Maseri A., Sabbadini M. G., Manfredi A. A. Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: a clue to thromboembolic risks? Autoimmunity: 2009; 42 4 386 388
45. Maugeri N., Rovere-Querini P., Baldini M., et al. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis. Antioxid Redox Signal: 2014; 20 7 1060 1074
46. Maugeri N., Rovere-Querini P., Slavich M., et al. Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. J Immunol: 2011; 187 2 970 979
47. Furman M. I., Kereiakes D. J., Krueger L. A., et al. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab. Am Heart J: 2001; 142 5 790 798
48. Gardiner E. E., De Luca M., McNally T., Michelson A. D., Andrews R. K., Berndt M. C. Regulation of P-selectin binding to the neutrophil P-selectin counter-receptor P-selectin glycoprotein ligand-1 by neutrophil elastase and cathepsin G. Blood: 2001; 98 5 1440 1447
49. Michelson A. D., Barnard M. R., Krueger L. A., Valeri C. R., Furman M. I. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation: 2001; 104 13 1533 1537
50. Kambas K., Markiewski M. M., Pneumatikos I. A., et al. C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome. J Immunol: 2008; 180 11 7368 7375
51. Maugeri N., Franchini S., Campana L., et al. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity: 2012; 45 8 584 587
52. Brambilla M., Camera M., Colnago D., et al. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol: 2008; 28 5 947 953
53. Camera M., Brambilla M., Facchinetti L., et al. Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res: 2012; 129 3 279 284
54. Evangelista V., Pamuklar Z., Piccoli A., et al. Src family kinases mediate neutrophil adhesion to adherent platelets. Blood: 2007; 109 6 2461 2469
55. Piccardoni P., Manarini S., Federico L., et al. SRC-dependent outside-in signalling is a key step in the process of autoregulation of beta2 integrins in polymorphonuclear cells. Biochem J: 2004; 380 (Pt 1): 57 65
56. Piccardoni P., Sideri R., Manarini S., et al. Platelet/polymorphonuclear leukocyte adhesion: a new role for SRC kinases in Mac-1 adhesive function triggered by P-selectin. Blood: 2001; 98 1 108 116
57. Maugeri N., de Gaetano G., Barbanti M., Donati M. B., Cerletti C. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin. Haematologica: 2005; 90 6 833 839
58. Maugeri N., Rovere-Querini P., Evangelista V., et al. Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and beta2 integrin-dependent cell clearance program. Blood: 2009; 113 21 5254 5265
59. Maugeri N., Di Fabio G., Barbanti M., de Gaetano G., Donati M. B., Cerletti C. Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood. Thromb Haemost: 2007; 97 6 965 973
60. Stakos D. A., Kambas K., Konstantinidis T., et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur Heart J: 2015; 36 22 1405 1414
61. Kambas K., Mitroulis I., Apostolidou E., et al. Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS ONE: 2012; 7 9 e45427
62. Kambas K., Chrysanthopoulou A., Vassilopoulos D., et al. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann Rheum Dis: 2014; 73 10 1854 1863
63. Brinkmann V., Reichard U., Goosmann C., et al. Neutrophil extracellular traps kill bacteria. Science: 2004; 303 5663 1532 1535
64. Urban C. F., Reichard U., Brinkmann V., Zychlinsky A. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol: 2006; 8 4 668 676
65. Engelmann B., Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol: 2013; 13 1 34 45
66. Thomas G. M., Carbo C., Curtis B. R., et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood: 2012; 119 26 6335 6343
67. Fuchs T. A., Brill A., Duerschmied D., et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A: 2010; 107 36 15880 15885
68. Brill A., Fuchs T. A., Savchenko A. S., et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost: 2012; 10 1 136 144
69. Pemberton A. D., Brown J. K., Inglis N. F. Proteomic identification of interactions between histones and plasma proteins: implications for cytoprotection. Proteomics: 2010; 10 7 1484 1493
70. Ward C. M., Tetaz T. J., Andrews R. K., Berndt M. C. Binding of the von Willebrand factor A1 domain to histone. Thromb Res: 1997; 86 6 469 477
71. Semeraro F., Ammollo C. T., Morrissey J. H., et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood: 2011; 118 7 1952 1961
72. Ammollo C. T., Semeraro F., Xu J., Esmon N. L., Esmon C. T. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost: 2011; 9 9 1795 1803
73. Massberg S., Grahl L., von Bruehl M. L., et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med: 2010; 16 8 887 896
74. Esmon C. T. Molecular circuits in thrombosis and inflammation. Thromb Haemost: 2013; 109 3 416 420
75. Remijsen Q., Vanden Berghe T., Wirawan E., et al. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res: 2011; 21 2 290 304
76. de Boer O. J., Li X., Teeling P., et al. Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb Haemost: 2013; 109 2 290 297
77. Giesen P. L., Rauch U., Bohrmann B., et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A: 1999; 96 5 2311 2315
78. Wang J. G., Manly D., Kirchhofer D., Pawlinski R., Mackman N. Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost: 2009; 7 7 1092 1098
79. Furie B., Furie B. C. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med: 2004; 10 4 171 178
80. Eleftheriou D., Hong Y., Klein N. J., Brogan P. A. Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle-mediated thrombin generation. J Thromb Haemost: 2011; 9 9 1864 1867
81. Hergesell O., Andrassy K., Nawroth P. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thromb Haemost: 1996; 75 6 892 898
82. Daniel L., Fakhouri F., Joly D., et al. Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int: 2006; 69 8 1416 1423
83. Delabranche X., Boisramé-Helms J., Asfar P., et al. Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med: 2013; 39 10 1695 1703
84. Nieuwland R., Berckmans R. J., McGregor S., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood: 2000; 95 3 930 935
85. Guervilly C., Lacroix R., Forel J. M., et al. High levels of circulating leukocyte microparticles are associated with better outcome in acute respiratory distress syndrome. Crit Care: 2011; 15 1 R31
86. Gasser O., Schifferli J. A. Microparticles released by human neutrophils adhere to erythrocytes in the presence of complement. Exp Cell Res: 2005; 307 2 381 387
87. Girardi G., Redecha P., Salmon J. E. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med: 2004; 10 11 1222 1226
88. McKeage K., Keating G. M. Parnaparin: a review of its use in the management of venous thromboembolism, chronic venous disease and other vascular disorders. Drugs: 2008; 68 1 105 122
89. Redecha P., Franzke C. W., Ruf W., Mackman N., Girardi G. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J Clin Invest: 2008; 118 10 3453 3461
90. Yarbro J. W. Mechanism of action of hydroxyurea. Semin Oncol: 1992; 19 3 09 1 10
91. Habets K. L., Huizinga T. W., Toes R. E. Platelets and autoimmunity. Eur J Clin Invest: 2013; 43 7 746 757
92. Collins C. E., Cahill M. R., Newland A. C., Rampton D. S. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology: 1994; 106 4 840 845
93. Ertenli I., Kiraz S., Arici M., et al. P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol: 1998; 25 6 1054 1058
94. Gasparyan A. Y., Stavropoulos-Kalinoglou A., Mikhailidis D. P., Douglas K. M., Kitas G. D. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int: 2011; 31 2 153 164
95. Apostolidou E., Skendros P., Kambas K., et al. Neutrophil extracellular traps regulate IL-1β-mediated inflammation in familial Mediterranean fever. Ann Rheum Dis: 2014;; doi: 10.1136/annrheumdis-2014-205958
96. Takeda I., Kaise S., Nishimaki T., Kasukawa R. Soluble P-selectin in the plasma of patients with connective tissue diseases. Int Arch Allergy Immunol: 1994; 105 2 128 134
97. Tang S., Zhang Y., Yin S. W., et al. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis. Clin Exp Immunol: 2015; 180 3 408 418
98. Saffarzadeh M., Preissner K. T. Fighting against the dark side of neutrophil extracellular traps in disease: manoeuvres for host protection. Curr Opin Hematol: 2013; 20 1 3 9
99. Horita T. Recent advances in pathogenesis and pathophysiology in the antiphospholipid syndrome [in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi: 2012; 35 6 481 494
100. Rossaint J., Zarbock A. Platelets in leucocyte recruitment and function. Cardiovasc Res: 2015; 107 386 395
101. Lv B., Wang H., Tang Y., Fan Z., Xiao X., Chen F. High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-kappaB and Egr-1. Thromb Haemost: 2009; 102 2 352 359
102. Ramirez G. A., Franchini S., Rovere-Querini P., Sabbadini M. G., Manfredi A. A., Maugeri N. The role of platelets in the pathogenesis of systemic sclerosis. Front Immunol: 2012; 3 160
103. Redecha P., Tilley R., Tencati M., et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood: 2007; 110 7 2423 2431